Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey.

Taniere, Phillipe; Nicholson, Andrew G; Gosney, John R; Montero Fernandez, Maria Angeles; Bury, Danielle; Moore, David Allan; Verghese, Eldo; Soomro, Irshad; Joseph, Leena; Bhatt, Nidhi; Viola, Patrizia; Bains, Rozinder; Lanctot, Adrienne G; Ryan, Jacqueline.

Afiliação

Taniere P; Histopathology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK phillipe.taniere@uhb.nhs.uk.
Nicholson AG; Respiratory Pathology, National Heart and Lung Institute, Imperial College London, London, UK.
Gosney JR; Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Montero Fernandez MA; Cellular Pathology, Royal Liverpool University Hospital, Liverpool, UK.
Bury D; Histopathology, Manchester University NHS Foundation Trust, Manchester, UK.
Moore DA; Histopathology, Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, UK.
Verghese E; Cellular Pathology, University College London Cancer Institute, London, UK.
Soomro I; Histopathology, St James's University Hospital, Leeds, UK.
Joseph L; Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Bhatt N; Histopathology, Manchester University NHS Foundation Trust, Manchester, UK.
Viola P; Cellular Pathology, North Bristol NHS Trust, Westbury on Trym, UK.
Bains R; Cellular Pathology, Imperial College Healthcare NHS Trust, London, UK.
Lanctot AG; Novartis Pharmaceuticals UK Ltd, London, UK.
Ryan J; Novartis Pharmaceuticals UK Ltd, London, UK.